Breast cancer patients may shorten Herceptin regimen: study
Breast cancer patients may shorten Herceptin regimen: study

For years, the drug Herceptin has helped women with an aggressive form of breast cancer beat the disease.

Earlier mammograms may mean less need for aggressive treatments
Earlier mammograms may mean less need for aggressive treatments

Much of the debate over when to start having mammograms has focused on lives saved, but new research suggests that early screening might also translate into smaller tumors and less aggressive breast cancer treatments.

Newer breast MRI may be more accurate and easier
Newer breast MRI may be more accurate and easier

A new type of MRI (magnetic resonance imaging) that doesn't use a contrast agent appears better at detecting what's really cancer and what's likely just a harmless lesion, researchers report.

Extra body fat may raise breast cancer risk, no matter your weight
Extra body fat may raise breast cancer risk, no matter your weight

Older women who carry some extra body fat may face a heightened risk of breast cancer -- even if their weight is normal, a new study finds.

Screening, treatment cuts breast cancer deaths in half
Screening, treatment cuts breast cancer deaths in half

Breakthroughs in breast cancer screening and treatment have slashed the percentage of women dying from the disease, a new analysis reveals.

Just a little weight loss may cut breast cancer risk
Just a little weight loss may cut breast cancer risk

It's never too late for women to lose weight to lower their breast cancer risk, a new study suggests.

New breast cancer drug may benefit younger women, too
New breast cancer drug may benefit younger women, too

Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.

Risk of breast cancer's return can linger for decades
Risk of breast cancer's return can linger for decades

Women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later, a large, new study shows.

Could 'AI' become a partner in breast cancer care?
Could 'AI' become a partner in breast cancer care?

Machines armed with artificial intelligence may one day help doctors better identify high-risk breast lesions that might turn into cancer, new research suggests.

Breast cancer more lethal for blacks than whites
Breast cancer more lethal for blacks than whites

Differences in insurance are a major reason why black women are more likely to die of breast cancer than white women in the United States, a new study contends.

Need cancer screening? Where you work matters
Need cancer screening? Where you work matters

Waiters, contractors and other employees of America's small businesses are more likely to miss out on cancer screening, mostly because of a lack of insurance, new research shows.

More women choose breast reconstruction after mastectomy
More women choose breast reconstruction after mastectomy

Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows.

Breast cancer screenings still best for early detection
Breast cancer screenings still best for early detection

Breast cancer is the second leading cause of cancer death among women in the United States, and routine screenings remain the most reliable way to detect the disease early, a breast cancer expert says.

How breast cancer gene mutations raise risk of tumors
How breast cancer gene mutations raise risk of tumors

Scientists say they've spotted how mutations in the BRCA1 gene can trigger breast cancer.

Breast cancer's decline may have saved 322,000 lives
Breast cancer's decline may have saved 322,000 lives

New research finds the number of American women who've lost their lives to breast cancer has fallen precipitously in the past 25 years, with more than 322,000 lives saved in that time.

Verzenio approved for advanced breast cancer
Verzenio approved for advanced breast cancer

Verzenio (abemaciclib) has been approved by the U.S. Food and Drug Administration to treat women with certain advanced forms of breast cancer, the most common cancer in the United States.

Yoga may bring better sleep to breast cancer patients
Yoga may bring better sleep to breast cancer patients

A certain type of yoga may provide lasting benefits for breast cancer patients who have trouble sleeping, researchers report.

Surgeons play big role in women's choices for breast cancer care
Surgeons play big role in women's choices for breast cancer care

A breast cancer patient's choice of surgeon can have a major effect on her treatment, according to a new study.

Managing pain can be a puzzle after breast cancer
Managing pain can be a puzzle after breast cancer

Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report.

'Cancer pen' could help surgeons spot tumor cells in seconds
'Cancer pen' could help surgeons spot tumor cells in seconds

A new "cancer pen" promises to help surgeons immediately detect and completely remove cancerous tumor tissue, without having to send samples off to a lab for testing while the patient languishes on the table.

Could urban lighting raise breast cancer risk for some women?
Could urban lighting raise breast cancer risk for some women?

New research reveals an unexpected potential risk factor for breast cancer: city lights.

Can a blood test detect a range of cancers earlier?
Can a blood test detect a range of cancers earlier?

A new genetic blood test might pave the way for detecting early stage cancers that often prove fatal when caught too late, a new study suggests.

Why breast cancer survivors should exercise
Why breast cancer survivors should exercise

Excessive stress can lead to memory problems among breast cancer survivors, but exercise can help, according to new research.

Cheaper breast cancer drug does well in clinical trial
Cheaper breast cancer drug does well in clinical trial

For women with advanced HER2-positive breast cancer, a similar but less expensive experimental drug works just as well as the standard drug Herceptin (trastuzumab), a new study finds.

Mindfulness meditation seems to soothe breast cancer survivors
Mindfulness meditation seems to soothe breast cancer survivors

Mindfulness meditation seems to help breast cancer patients better manage symptoms of fatigue, anxiety and fear of recurrence, a new study suggests.

Lifestyle change may cut risk for women with breast cancer genes
Lifestyle change may cut risk for women with breast cancer genes

Women who carry common gene variants linked to breast cancer can still cut their risk of the disease by following a healthy lifestyle, a large new study suggests.

Many breast cancer patients try alternative medicine first
Many breast cancer patients try alternative medicine first

Women with early stage breast cancer who turn to alternative medicine may delay recommended chemotherapy, a new study suggests.

Celebrity cases may help spur rise in double mastectomies
Celebrity cases may help spur rise in double mastectomies

Media coverage of celebrities who battle breast cancer is not always balanced or thorough, and this skewed view may be one factor in the growing popularity of double mastectomies, a new study suggests.

Evening snacking might raise odds for breast cancer's return
Evening snacking might raise odds for breast cancer's return

Breast cancer patients fond of midnight snacking may be at a higher risk of a breast cancer recurrence, according to new research.

With early breast cancer, targeted radiation shows promise
With early breast cancer, targeted radiation shows promise

For women with early stage breast cancer, targeted doses of radiation therapy may be as effective as standard radiation treatment of the entire breast, a new British study suggests.